Craniofacial Mucormycosis: A Case Report

Yıl 2009, Cilt: 14 Sayı: 3, 210 - 212, 01.06.2009

Mehmet Erkaleli İnci Alacacıoğlu Bahriye Payzın Murat Ermete Sakine Leyla Arslan

Öz

Craniofacial-rhinocerebral mucormycosis is a rare and life-threatening invasive fungal infection which results in high mortality. It is most often found in patients with hematologic malignancy, diabetic ketoacidosis, organ transplantation, HIV disease, drug abuse and haemodialysis. Rhinocerebral mucormycosis is the most common form. The patient was admitted to our hospital because of relapsed leukemia. He was treated with salvage chemotherapy with G-CSF support and also treated with antibiotherapy including antifungal agent due to neutropenic fever. He developed a necrotic lesions at nares, hard palate and skin. Craniofacial mucormycosis was diagnosed with physical and histopathologic findings. Although the patient was given an antifungal therapy he didn't improve and died. This case was reported to emphasize the mucormycosis which results in high mortality.

Anahtar Kelimeler

-

Kraniofasiyal Mukormikoz: Bir Olgu Sunumu

Öz

Kraniofasiyal-rinoserebral mukormikoz yüksek mortaliteye sahip, nadir görülen invaziv bir fungal infeksiyondur. Sıklıkla hamatolojik malignitelerde, diyabetik ketoasidozda, organ transplantasyonlarında, HIV infeksiyonunda, ilaç bağımlılarında ve hemodiyaliz hastalarında görülür. Rinoserebral formu en sık görülen formudur. Hasta relaps akut lösemi tanısıyla tedavi amaçlı yatırıldı. Büyüme faktör(G-CSF) destekli kurtarma kemoterapisi uygulanan hastaya nötropenik ateş nedeniyle antifungal tedavi dahil antibiyotik tedavisi başlandı. İzlemde burunda, sert damakta ve ciltte nekrotik lezyonlar gelişti. Fizik muayene ve histolojik bulgular ile kraniofasiyal mukormikoz olarak teşhis edildi. Ancak antifungal tedaviye rağmen gittikçe kötüleşti ve kaybedildi. Bu olgu yüksek mortaliteyle seyreden mukormikoz infeksiyonlarını vurgulamak için sunuldu.

Anahtar Kelimeler

Mukor, mukormikoz, lösemi, kraniofasiyal

Kaynakça

• Eucker J, Sezer O, Graf B, Possinger K. Mucormycoses. Mycoses 2001; 44:253-260.
• Pagano L, Ricci P, Tonso A, Nosari A, Cudillo L, Montillo M, et al. Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. Br J Haematol 1997; 99:331-336.
• Pfaffenbach B, Donhuijsen K, Pahnke J, Bug R, Adamek RJ, Wegener M, et al. Systemic fungal infections in hematologic neoplasms. An autopsy study of 1,053 patients. Med Klin 1999; 89:299-304.
• Pagano L, Ricci P, Nosari A, Tonso A, Buelli M, Montillo M, et al. Fatal haemoptysis in pulmonary filamentous mycosis: an underevaluated cause of death in patients with acute leukaemia in haematological complete remission. A retrospective study and review of the literature. Gimema Infection Program (Gruppo Italiano Malattie Ematologiche dell'Adulto). Br J Haematol 1995; 89:500-505.
• Sugar AM. Mucormycosis. Clin Infect Dis 1994;14 Suppl 1:126-129.
• Lehrer RI, Howard DH, Sypherd PS, Edwards JE, Segal GP, Winston DJ. Mucormycosis. Ann Intern Med 1980; 93:93108.
• Morrison VA, McGlave PB. Mucormycosis in the BMT population. Bone Marrow Transplant 1993; 11:383-388.
• Blin N, Morineau N, Gaillard F, Morin O, Milpied N, Harousseau JL, et al. Disseminated mucormycosis associated with invasive pulmonary aspergillosis in a patient treated for post-transplant high-grade non-Hodgkin's lymphoma. Leuk Lymphoma 2004; 45:2161-2163.
• St-Germain G, Robert A, Ishak M, Tremblay C, Claveau S. Infection due to Rhizomucor pusillus: report of four cases in patients with leukemia and review. Clin Infect Dis 1993; 16:640-645.
• Tedder M, Spratt JA, Anstadt MP, Hedge SS, Tedder SD, Lowe JE. Pulmonary mucormycosis: results of medical and surgical therapy. Ann Thorac Surg 1994;57:1044-1050.
• Kontoyiannis DP, Wessel VC, Bodey GP, Rolston KV. Zygomycosis in the 1990s in a tertiary-care cancer center. Clin Infect Dis 2000; 30:851-856.
• Tonso A, Ricci P, Cenacchi A, Bonini A, Ficara F, Pagano L. Invasive infections by fylamentous mycetes in adult patients with hematological neoplastic diseases (polycentric and retrospective study of 162 cases). Haematologica 1993; 78 Suppl 4:24.
• Pagano L, Offidani M, Fianchi L, Nosari A, Candoni A, Piccardi M, et al. Mucormycosis in hematologic patients. Haematologica 2004; 89:207-214.
• Sugar AM. Agents of mucormycosis and related species. In: Mandell GL, Bennett JE, Dolin R (eds) Principles and practice of infectious diseases. Churchill-Livingstone, Philadelphia, 2000; 2685-2695.